help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Trotsenburg, A. S. P.
Right arrow Articles by de Vijlder, J. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Trotsenburg, A. S. P.
Right arrow Articles by de Vijlder, J. J. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 4 1512-1515
Copyright © 2003 by The Endocrine Society

Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns

A. S. P. van Trotsenburg, T. Vulsma, H. M. van Santen, W. Cheung and J. J. M. de Vijlder

Department of Pediatric Endocrinology, Emma Children’s Hospital AMC, 1105 AZ Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: A. S. Paul van Trotsenburg, M.D., Department of Pediatric Endocrinology, Emma Children’s Hospital AMC, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail: a.s.vantrotsenburg{at}amc.uva.nl.

There is an unexplained higher incidence of congenital hypothyroidism (CH) detected by T4-based neonatal screening programs and a very high prevalence of (mild) plasma TSH elevation in young children with Down syndrome (DS). To determine whether newborns with DS have decreased blood T4 concentrations at the time of the neonatal screening, we conducted an observational study in a large and representative cohort of Dutch children with DS born in 1996 and 1997. CH screening results (T4, TSH, and T4-binding globulin concentrations) were analyzed in comparison with clinical information obtained by interviewing the parents and data from the general newborn population and a large control group. The mean T4 concentration of the studied children with DS (n = 284) was significantly decreased. The individual T4 concentrations were normally (Gaussian) distributed but shifted to lower concentrations. This could not be explained by prematurity, nonthyroidal illness, or iodine exposure. Mean TSH and T4-binding globulin concentrations were significantly increased and normal, respectively. The decreased T4 concentration, left-shifted normal distribution, and mildly elevated TSH concentrations point to a mild hypothyroid state in newborns with DS and support the existence of a DS-specific thyroid (regulation) disorder. The question remains whether this contributes to the brain maldevelopment.

This work was partly supported by a grant from the Stichting tot Steun Emma Kinderziekenhuis AMC.

Abbreviations: CH, Congenital hypothyroidism; DS, Down syndrome; FT4, free T4; NTI, nonthyroidal illness; TBG, T4-binding globulin.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. E. Kempers, C. I. Lanting, A. F. J. van Heijst, A. S. P. van Trotsenburg, B. M. Wiedijk, J. J. M. de Vijlder, and T. Vulsma
Neonatal Screening for Congenital Hypothyroidism Based on Thyroxine, Thyrotropin, and Thyroxine-Binding Globulin Measurement: Potentials and Pitfalls
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3370 - 3376.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. S. P. van Trotsenburg, B. J. Smit, J. H. T. M. Koelman, M. Dekker-van der Sloot, J. C. D. Ridder, J. G. P. Tijssen, J. J. M. de Vijlder, and T. Vulsma
Median Nerve Conduction Velocity and Central Conduction Time Measured With Somatosensory Evoked Potentials in Thyroxine-Treated Infants With Down Syndrome
Pediatrics, September 1, 2006; 118(3): e825 - e832.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. S. P. van Trotsenburg, T. Vulsma, S. L. R. van Rozenburg-Marres, A. L. van Baar, J. C. D. Ridder, H. S. A. Heymans, J. G. P. Tijssen, and J. J. M. de Vijlder
The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3304 - 3311.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
G Van Vliet
How often should we screen children with Down's syndrome for hypothyroidism?
Arch. Dis. Child., June 1, 2005; 90(6): 557 - 558.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
P A Gibson, R W Newton, K Selby, D A Price, K Leyland, and G M Addison
Longitudinal study of thyroid function in Down's syndrome in the first two decades
Arch. Dis. Child., June 1, 2005; 90(6): 574 - 578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society